Related Experiment Video
Updated: Aug 9, 2026
09:35
Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
[Immune disorders in hemophiliac patients]
Terapevticheskii Arkhiv
|January 1, 1987
Summary
Transfusion therapy in hemophilia patients can alter immune status, decreasing T-lymphocytes and increasing immune complexes. Monitoring immune function is crucial for managing hemophilia treatment.
Area of Science:
- Immunology
- Hematology
- Transfusion Medicine
Background:
- Hemophilia is a bleeding disorder requiring regular transfusion therapy.
- Transfusion therapy can impact the immune system.
- Understanding these immune changes is vital for patient care.
Purpose of the Study:
- To investigate immune status changes in hemophiliac patients receiving transfusion therapy.
- To correlate immune alterations with the dosage and duration of antihemophilic drug use.
Main Methods:
- Analysis of immune parameters including T-lymphocyte subsets (T-helpers, T-suppressors).
- Assessment of immunoglobulin levels and circulating immune complexes.
- Correlation of immune changes with transfusion therapy details.
Main Results:
- Transfusion therapy led to decreased T-lymphocytes and an altered T-helper/T-suppressor ratio.
- Elevated immunoglobulin production and increased circulating immune complexes were observed.
- The extent of immune changes was dose- and duration-dependent on antihemophilic drug administration.
Conclusions:
- Hemophiliac patients undergoing transfusion therapy experience significant immune dysregulation.
- Immunological monitoring is essential for hemophilia patients.
- Optimizing antihemophilic drug dosage and administration duration is critical for mitigating immune complications.
Related Concept Videos
01:36Humoral Immune Responses
Overview
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...